AngioDynamics ANGO Income Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $313.73M+2.1% | $307.31M+2.2% | $300.72M+2.8% | $292.5M+3.2% | $283.32M-1.1% | ||
| $143.39M+2.7% | $139.59M+1.2% | $137.88M+2.3% | $134.79M+4.2% | $129.32M-4.6% | ||
| $170.34M+1.6% | $167.72M+3.0% | $162.84M+3.3% | $157.71M+2.4% | $154M+2.0% | ||
| 54.3%-0.3pp | 54.6%+0.4pp | 54.1%+0.2pp | 53.9%-0.4pp | 54.4%+1.6pp | ||
| $27.86M+0.6% | $27.69M+5.1% | $26.35M+0.5% | $26.22M-0.5% | $26.36M-4.6% | ||
| $108.72M+1.8% | $106.78M+1.1% | $105.66M+2.4% | $103.14M+1.8% | $101.28M+0.1% | ||
| $43.66M+0.5% | $43.43M-0.5% | $43.67M+3.8% | $42.09M-0.5% | $42.3M-0.2% | ||
| $205.86M+2.8% | $200.26M0.0% | $200.35M+1.4% | $197.66M-2.4% | $202.62M-48.9% | ||
| -$35.52M-9.1% | -$32.54M+13.2% | -$37.51M+6.1% | -$39.95M+17.8% | -$48.62M+79.6% | ||
| -11.3%-0.7pp | -10.6%+1.9pp | -12.5%+1.2pp | -13.7%+3.5pp | -17.2%+66.1pp | ||
| -$191K-697% | $32K-91.3% | $368K-62.4% | $978K+140% | $408K+437% | ||
| —— | —— | —— | —— | $4.94M+1,148% | ||
| -$31.38M-13.2% | -$27.71M+14.0% | -$32.21M+5.4% | -$34.03M+19.1% | -$42.06M+82.3% | ||
| $12K+700% | -$2K+98.1% | -$107K-174% | -$39K+94.2% | -$671K+94.7% | ||
| -$31.39M-13.3% | -$27.71M+13.7% | -$32.1M+5.6% | -$33.99M+17.9% | -$41.39M+81.6% | ||
| -10%-1.0pp | -9%+1.7pp | -10.7%+0.9pp | -11.6%+3.0pp | -14.6%+63.8pp | ||
| -$0.75-11.9% | -$0.67+14.1% | -$0.78+6.0% | -$0.83+17.8% | -$1.01+81.9% | ||
| -$12.33M-43.0% | -$8.62M+30.9% | -$12.48M+11.8% | -$14.15M+35.2% | -$21.83M+89.6% | ||
| -3.9%-1.1pp | -2.8%+1.3pp | -4.1%+0.7pp | -4.8%+2.9pp | -7.7%+65.8pp | ||
| -$35.52M-9.1% | -$32.54M+13.2% | -$37.51M+6.1% | -$39.95M+17.8% | -$48.62M+79.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is AngioDynamics's revenue?
- AngioDynamics (ANGO) generated $313.7M in revenue over the trailing twelve months, up 10.7% year over year.
- Is AngioDynamics profitable?
- AngioDynamics is not currently profitable: it reported a net loss of $31.4M over the trailing twelve months, a -10.0% net margin.
- What are AngioDynamics's profit margins?
- Gross margin is 54.3% and operating margin is -11.3%, with a -10.0% net margin.
- What is AngioDynamics's earnings per share?
- AngioDynamics's diluted EPS over the trailing twelve months is $-0.75.
- Where does AngioDynamics's income statement data come from?
- Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
